VRTX Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

$213.45  +3.17 (1.51%)
As of 04/09/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/08/2001
Outstanding shares:  258,821,254
Average volume:  1,746,226
Market cap:   $55,219,514,541
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92532F100
ISIN:        US92532F1003
Sedol:      2931034
Valuation   (See tab for details)
PE ratio:   20.36
PB ratio:   6.38
PS ratio:   8.90
Return on equity:   31.22%
Net income %:   43.70%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy